Regulus Therapeutics Inc. (RGLS)
NASDAQ: RGLS · IEX Real-Time Price · USD
2.880
0.00 (0.00%)
At close: Mar 28, 2024, 4:00 PM
2.910
+0.030 (1.04%)
After-hours: Mar 28, 2024, 7:54 PM EDT
Regulus Therapeutics Market Cap
Regulus Therapeutics has a market cap or net worth of $188.54 million as of March 28, 2024. Its market cap has increased by 965.20% in one year.
Market Cap
188.54M
Enterprise Value
167.10M
1-Year Change
965.20%
Ranking
Category
Stock Price
$2.88
Market Cap Chart
Since December 31, 2012, Regulus Therapeutics's market cap has decreased from $225.70M to $188.54M, a decrease of -16.46%. That is a compound annual growth rate of -1.59%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 188.50M | 1.24% |
Mar 26, 2024 | 186.20M | 0.87% |
Mar 25, 2024 | 184.60M | 5.01% |
Mar 22, 2024 | 175.80M | -3.41% |
Mar 21, 2024 | 182.00M | 259.68% |
Mar 20, 2024 | 50.60M | 4.98% |
Mar 19, 2024 | 48.20M | 1.05% |
Mar 18, 2024 | 47.70M | 11.71% |
Mar 15, 2024 | 42.70M | -13.56% |
Mar 14, 2024 | 49.40M | 0.61% |
Mar 13, 2024 | 49.10M | 2.94% |
Mar 12, 2024 | 47.70M | 70.97% |
Mar 11, 2024 | 27.90M | -0.71% |
Mar 8, 2024 | 28.10M | -2.09% |
Mar 7, 2024 | 28.70M | -5.28% |
Mar 6, 2024 | 30.30M | 1.34% |
Mar 5, 2024 | 29.90M | -0.66% |
Mar 4, 2024 | 30.10M | - |
Mar 1, 2024 | 30.10M | 1.35% |
Feb 29, 2024 | 29.70M | -1.33% |
Feb 28, 2024 | 30.10M | -0.99% |
Feb 27, 2024 | 30.40M | 5.92% |
Feb 26, 2024 | 28.70M | -2.71% |
Feb 23, 2024 | 29.50M | -4.53% |
Feb 22, 2024 | 30.90M | 1.31% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Quipt Home Medical | 182.64M |
Harvard Bioscience | 180.97M |
Adicet Bio | 179.92M |
Orchestra BioMed Holdings | 178.72M |
ClearPoint Neuro | 177.23M |
Aldeyra Therapeutics | 171.09M |
Telomir Pharmaceuticals | 169.88M |
Rani Therapeutics Holdings | 167.90M |